03/03
Headlines

Colin Pettis

Colin Pettis covers the senior semiconductor sector and is a managing director at Tech Insider, joining in 2012. Colin has 20 years of experience in equity research including 15 years in semiconductor components. Colin is currently responsible for the coverage of 18 large-cap and small-cap semiconductor companies.

Trending Tickers : Goldcorp Inc. (NYSE:GG), Zoetis Inc. (NYSE:ZTS), Intrawest Resorts Holdings, Inc. (NYSE:SNOW), McGraw Hill Financial, Inc. (NYSE:MHFI), Autodesk, Inc. (NASDAQ:ADSK)

Colin Pettis03 mins

Goldcorp (NYSE:GG) declared a monthly dividend on Tuesday, October 7th, Stock Ratings News reports. Shareholders of record on Thursday, October 16th will be given a dividend of 0.05 per share on Friday, October 24th. This represents a $0.60 dividend on an annualized basis and a yield of 2.66%. The ex-dividend date of this dividend is…

Read More
FB Nasdaq FB Facebook

BAER Finishes Off Strong 2Q

Colin Pettis02 mins

Baer’s reported net income for the first half of CHF 114 million includes a significant amount of acquisition, integration, and one-off items. On an underlying basis, the bank’s net profit was CHF 261 million for the first half, up 26% from the year-ago half, as the bank benefited from higher assets under management and increased…

Read More

Best Stocks : Merck & Co. Inc. (NYSE:MRK), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), American Campus Communities, Inc. (NYSE:ACC), Kosmos Energy Ltd. (NYSE:KOS), NRZ

Colin Pettis03 mins

Drugmaker Merck said on Oct 01, that it completed the sale of its consumer care business, which makes products including Claritin allergy medication and Coppertone sun-care line, to German health care company Bayer for $14.2 billion. Merck & Co. Inc. (NYSE:MRK) belongs to Healthcare sector. Its net profit margin is 12.90% and weekly performance is…

Read More

Big Movers : BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Mirati Therapeutics, Inc. (NASDAQ:MRTX), Eastman Chemical Co. (NYSE:EMN), Pike Corporation (NYSE:PIKE), General Motors Company (NYSE:GM)

Colin Pettis02 mins

BioCryst Pharmaceuticals (NASDAQ:BCRX) CFO Thomas R. Staab II unloaded 10,000 shares of BioCryst Pharmaceuticals stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $13.58, for a total transaction of $135,800.00. Following the completion of the transaction, the chief financial officer now directly owns 162,942 shares…

Read More

Hot Stock List : American Airlines Group Inc. (NASDAQ:AAL), Magnum Hunter Resources Corp. (NYSE:MHR), Fresh Del Monte Produce Inc. (NYSE:FDP), POWL, BA

Colin Pettis03 mins

American Airlines Group Inc. (NASDAQ:AAL) plans to replace jets from its regional unit Envoy Air Inc out of Miami with larger ones from a Republic Airways Inc unit, leading to about 50 job cuts at Envoy. The move follows Envoy pilots’ vote in March to reject a new labor contract including a wage freeze and…

Read More

Today’s Watch List : SeaDrill Limited (NYSE:SDRL), GreenHunter Resources, Inc. (NYSEMKT:GRH), CTI BioPharma Corp. (NASDAQ:CTIC), Eli Lilly and Company (NYSE:LLY), TSLA

Colin Pettis03 mins

Wells Fargo & Co. reiterated their underperform rating on shares of Seadrill (NASDAQ:SDRL) in a research report released on Wednesday morning. SeaDrill Limited (NYSE:SDRL) shares fell -2.43% in last trading session and ended the day at $24.85. SDRL Gross Margin is 57.90% and its return on assets is 15.90%. SeaDrill Limited (NYSE:SDRL) quarterly performance is…

Read More